Angiotensin II receptor blocker: Difference between revisions
No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
|販売 | |販売 | ||
|[[Boehringer Ingelheim]] | |[[Boehringer Ingelheim]] | ||
| | |||
|- | |- | ||
|} | |} | ||
No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
|販売 | |販売 | ||
|[[Boehringer Ingelheim]] | |[[Boehringer Ingelheim]] | ||
| | |||
|- | |- | ||
|} | |} | ||